Table 4. Frequencies of LR defects upon manipulation of presumed early determinants vs. Coco.
factor | treatment | frequency | references |
---|---|---|---|
| |||
ion channels | various inhibitors | 15-51% | Adams et al, 2006; Aw et al, 2010; 2008; Levin et al, 2002; Morokuma et al, 2008 |
various mRNA injections | 9-44% | ||
| |||
Serotonin signaling | various inhibitors | 10-44% | Fukumoto et al., 2005b; 2005a; Rea et al., 2013; Vandenberg et al., 2013a |
various mRNA injections | 11-56% | ||
| |||
cytoskeleton | various inhibitors | 19-38% | Lobikin et al., 2012; Qiu et al., 2005 |
various mRNA injections | 8-32,5%a | ||
| |||
Other factors | various inhibitors | 22,5-25%b | Bunney et al., 2003; Carneiro et al, 2011; Vandenberg and Levin, 2013; 2012 |
various mRNA injections | 5-75%c | ||
| |||
Coco | MO-mediated Knockdown (right) | 70-98% | Schweickert et al., 2010; Tingler et al., n.d.; Vonica and Brivanlou, 2007 |
DNA or mRNA injections (left) | 83-100% |
excluding one outlier experiment with one construct (tub4a; Lobikin et al., 2012), which caused misexpression of Nodal in 64,7% of cases (cf. Table S3).
excluding one part of a NaB-HDAC-inhibitor experiment which caused misexpression of Nodal in 64% of an unknown number of cases (cf. Table S4).